EU regulator expects J&J vaccine application ‘shortly’

Credit: Pixabay/CC0 Public Domain

The EU’s medicines watchdog said on Friday that it expects Johnson and Johnson to submit an application for its coronavirus vaccine “shortly” after it published “promising” results from a large trial.

“We’ve just heard some promising results from the Janssen vaccine, which hope to be submitted shortly to us,” European Medicines Agency chief Emer Cooke told a press conference, referring to Johnson & Johnson’s European subsidiary Jansen-Cilag.

“This is currently subject to a rolling review which precedes the formal marketing authorisation application submission,” said Cooke.

Read:It’s crucial we address COVID vaccine hesitancy among health workers. Here’s where to start

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2021 AFP

Read:Very little spread of coronavirus at kids’ day camps: study

EU regulator expects J&J vaccine application ‘shortly’ (2021, January 29)
retrieved 29 January 2021

Read:Drug being tested for at-home treatment in hopes of slowing virus

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Previous post
A computational approach to understanding how infants perceive language
Next post
German panel keeps advice against AstraZeneca jabs for over-65s